Trial Profile
A Two-Part Study to Assess the Effects of Ritonavir on PRN1008 Pharmacokinetics, and the Effects of PRN1008 on QTc Interval Compared to Placebo and Moxifloxacin in Healthy Participants
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Rilzabrutinib (Primary) ; Ritonavir
- Indications Autoimmune disorders; Idiopathic thrombocytopenic purpura; Pemphigus vulgaris
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Principia Biopharma
- 27 Jun 2018 New trial record